Clinical Trial Update: Prevention of Colic With the Probiotic Lactobacillus Reuteri [Phase 2, Phase 3]

View source ↗

Summary

This document provides an update on a clinical trial evaluating the prevention of infant colic using the probiotic Lactobacillus reuteri in Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infant Colic

Drugs mentioned

• Lactobacillus reuteri DSM 17938 (Lactobacillus reuteri DSM 17938)

Snippet

Sponsor: Hospital General Naval de Alta Especialidad - Escuela Medico Naval | Conditions: Colic | Phase 2, Phase 3 | Status: UNKNOWN